Assessing Quality of Life in Hepatitis C Patients: Improvements Following Direct-Acting Antiviral Therapy—A Single-Center Romanian Study
Open Access
- 21 November 2025
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 13 (23) , 3007
Abstract
Background/Objectives: The Hepatitis C Virus (HCV) affects both physical health and overall well-being. The advent of direct-acting antivirals (DAAs) has greatly improved treatment outcomes. This study aimed to evaluate changes in quality of life (QoL) before and after DAA therapy. Methods: Ninety-seven patients with chronic HC were assessed using the SF-36v2 Health Survey, which measures eight physical and mental health domains. The questionnaire was administered at baseline (before treatment) and 12 weeks after achieving a sustained virological response (SVR). Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were calculated. Results: Statistically significant improvements were observed across multiple domains, including Physical Functioning (mean increase: +3.99, p < 0.001), General Health (+5.51, p < 0.001), and Vitality (+4.44, p < 0.001). Both PCS and MCS scores improved after therapy, indicating enhanced overall well-being. Subgroup analyses suggested greater physical gains among older patients and those with cirrhosis. Conclusions: Successful HCV treatment with DAAs improves not only virological outcomes but also patients’ day-to-day functioning and emotional health. Routine integration of QoL assessments is essential to capture the full spectrum of benefits offered by modern antiviral therapy.Keywords
This publication has 26 references indexed in Scilit:
- Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of LifeQuality of Life Research, 2025
- Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019The Lancet Public Health, 2023
- Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)Quality of Life Research, 2023
- The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysisAnnals of Hepatology, 2022
- HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysisHepatology, 2022
- Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysisScientific Reports, 2021
- Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological responseQuality of Life Research, 2021
- Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyThe Lancet, 2019
- The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic diseaseJournal of Viral Hepatitis, 2018
- Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimensAlimentary Pharmacology & Therapeutics, 2015